Details of the Drug Combinations | DrugMAP

General Information of This Drug (ID: DMNABMU)

Drug Name

GS-4997 DMNABMU

Indication

Disease Entry	ICD 11	Status	REF
Diabetic nephropathy	GB61.Z	Phase 2	[1]
Pulmonary arterial hypertension	BB01.0	Phase 2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
GS-4997 + Prednisolone	DCPWXEJ	Prednisolone	Severe Alcoholic Hepatitis	[3]
GS-4997 + Prednisolone	DC2HNH9	Prednisolone	Alcoholic Hepatitis (AH)	[4]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02234141) GS-4997 in Adults With Pulmonary Arterial Hypertension. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	ClinicalTrials.gov (NCT03087968) Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
4	ClinicalTrials.gov (NCT02854631) Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)